OP021 Autologous haematopoietic stem cell transplantation for Crohn’s disease: a retrospective study from the European Society for Blood Marrow Transplantation (EBMT) Autoimmune Diseases Working Party (original ) (raw )Ranking microbiome variance in inflammatory bowel disease: a large longitudinal intercontinental study
Kathryn Sexton
Gut, 2020
View PDFchevron_right
The Treatment-Naive Microbiome in New-Onset Crohn’s Disease
Jeffrey Hyams , Sandra Kim
Cell Host & Microbe, 2014
View PDFchevron_right
Alteration of the Gut Microbiome for Patients with Inflammatory Bowel Disease: A Review
Sherif Edris
Applied Ecology and Environmental Research, 2020
View PDFchevron_right
Gut mucosal-associated microbiota better discloses inflammatory bowel disease differential patterns than faecal microbiota
lorenza putignani
Digestive and Liver Disease, 2018
View PDFchevron_right
Fecal Microbial Composition of Ulcerative Colitis and Crohn’s Disease Patients in Remission and Subsequent Exacerbation
Paul Savelkoul
PLoS ONE, 2014
View PDFchevron_right
Disease-Specific Enteric Microbiome Dysbiosis in Inflammatory Bowel Disease
Inge Nordgaard-Lassen
Frontiers in Medicine, 2018
View PDFchevron_right
Australia IBD Microbiome (AIM) Study: protocol for a multicentre longitudinal prospective cohort study
Rupert Leong
BMJ Open, 2021
View PDFchevron_right
Dominant fecal microbiota in newly diagnosed untreated inflammatory bowel disease patients
Petr Ricanek
2013
View PDFchevron_right
Human Gut Microbiome Transplantation in Ileitis Prone Mice: A Tool for the Functional Characterization of the Microbiota in Inflammatory Bowel Disease Patients
abdullah osme
Inflammatory Bowel Diseases, 2019
View PDFchevron_right
Specificities of the fecal microbiota in inflammatory bowel disease
Joël Doré
Inflammatory Bowel Diseases, 2006
View PDFchevron_right
High-throughput clone library analysis of the mucosa-associated microbiota reveals dysbiosis and differences between inflamed and non-inflamed regions of the intestine in inflammatory bowel disease
Barry Hudspith
BMC Microbiology, 2011
View PDFchevron_right
The first international Rome consensus conference on gut microbiota and faecal microbiota transplantation in inflammatory bowel disease
Fabio Cominelli
Gut, 2023
View PDFchevron_right
Landscapes and bacterial signatures of mucosa-associated intestinal microbiota in Chilean and Spanish patients with inflammatory bowel disease
Nayaret Chamorro
Microbial Cell, 2021
View PDFchevron_right
Studying the enteric microbiome in inflammatory bowel diseases: getting through the growing pains and moving forward
Vincent Young
Front Microbiol, 2011
View PDFchevron_right
Twin studies reveal specific imbalances in the mucosa-associated microbiota of patients with ileal Crohnʼs disease
Janet Jansson
Inflammatory Bowel Diseases, 2009
View PDFchevron_right
Increased Intestinal Microbial Diversity Following Fecal Microbiota Transplant for Active Crohnʼs Disease
Joshua Korzenik
Inflammatory Bowel Diseases, 2016
View PDFchevron_right
Overrepresentation of Enterobacteriaceae and Escherichia coli is the major gut microbiome signature in Crohn’s disease and ulcerative colitis; a comprehensive metagenomic analysis of IBDMDB datasets
Babak Khorsand
Frontiers in Cellular and Infection Microbiology, 2022
View PDFchevron_right
Ulcerative colitis and irritable bowel patients exhibit distinct abnormalities of the gut microbiota
Elizabeth Lund
BMC Gastroenterology, 2010
View PDFchevron_right
Alterations of mucosal microbiota in the colon of patients with inflammatory bowel disease revealed by real time polymerase chain reaction amplification of 16S ribosomal ribonucleic acid
Srinivasan Pugazhendhi
Indian Journal of Medical Research, 2015
View PDFchevron_right
Faculty of 1000 evaluation for The treatment-naive microbiome in new-onset Crohn's disease
Morten Vatn
F1000 - Post-publication peer review of the biomedical literature, 2015
View PDFchevron_right
The Impact of Microbiome Interventions on the Progression and Severity of Inflammatory Bowel Disease: A Systematic Review
sobia nawaz
Curēus, 2024
View PDFchevron_right
P846 Comparative study of faecal microbiota in Crohn’s disease patients in remission with and without surgical resection
Anna Bahí
Journal of Crohn's and Colitis, 2020
View PDFchevron_right
Dysbiosis of fecal microbiota in Crohn's disease patients as revealed by a custom phylogenetic microarray
Joël Doré , Marion Leclerc
2010
View PDFchevron_right
Analysis of bacterial bowel communities of IBD patients: What has it revealed?
Gerald Tannock
Inflammatory Bowel Diseases, 2008
View PDFchevron_right
Exploring how microbiome signatures change across inflammatory bowel disease conditions and disease locations
Sjoerd Rijpkema
Scientific Reports, 2021
View PDFchevron_right
Features of Fecal and Colon Microbiomes Associate With Responses to Biologic Therapies for Inflammatory Bowel Diseases: A Systematic Review
Cátia Rocha
Clinical Gastroenterology and Hepatology, 2019
View PDFchevron_right
Multicenter analysis of fecal microbiota profiles in Japanese patients with Crohn’s disease
Fumihito Hirai
Journal of Gastroenterology, 2012
View PDFchevron_right
Unstable Composition of the Fecal Microbiota in Ulcerative Colitis During Clinical Remission
Maria Antolin , Cristina Martínez
The American Journal of Gastroenterology, 2008
View PDFchevron_right
Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach
Joël Doré
Gut, 2006
View PDFchevron_right
The application of omics techniques to understand the role of the gut microbiota in inflammatory bowel disease
A. Acharjee
Therapeutic Advances in Gastroenterology, 2019
View PDFchevron_right
Gut microbiota in pathophysiology, diagnosis, and therapeutics of inflammatory bowel disease
Daryl Tang
Intestinal Research
View PDFchevron_right
Microbial Signatures as a Predictive Tool in IBD—Pearls and Pitfalls
Amira Metwaly
Inflammatory Bowel Diseases
View PDFchevron_right